Literature DB >> 8976286

Mechanisms by which fibrin and fibronectin appear in healing wounds: implications for Peyronie's disease.

L Van de Water1.   

Abstract

PURPOSE: The extracellular matrix that is present at sites of tissue repair in most instances undergoes an orderly transition from a fibrin containing matrix to collagen-rich scar. However, in some conditions, such as Peyronie's disease, fibrin persists. Evidence from a number of experimental systems indicates that extracellular matrix proteins and their receptors serve an important function in regulating cell behaviors. Thus, the presence of the fibrin matrix is likely to have important implications in the course of either normal or pathogenic wound healing as occurs in Peyronie's disease. Potential mechanisms by which the fibrin rich provisional matrix appears in healing wounds are presented.
MATERIALS AND METHODS: Methodologies, such as in situ hybridization, immunolocalization and labeled tracer techniques, were used in our study.
RESULTS: We found by these approaches that the 2 general mechanisms that contribute to the generation of the wound extracellular matrix are leakage of plasma proteins, such as plasma fibronectin and fibrinogen, and the synthesis of variants of fibronectin by wound cells.
CONCLUSIONS: Developing an understanding of the mechanisms that regulate the appearance of these matrix proteins may provide new avenues for therapy in conditions such as Peyronie's disease in which the temporal pattern of the provisional matrix deposition is abnormal.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8976286     DOI: 10.1097/00005392-199701000-00103

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  The contribution of the immune system to genitourinary fibrosis.

Authors:  Karen M Doersch; Daniel Barnett; Abbie Chase; Daniel Johnston; J Scott Gabrielsen
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-07

2.  The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease.

Authors:  Can Tuygun; Ugur Hakki Ozok; Adnan Gucuk; I Halil Bozkurt; M Abdurrahim Imamoglu
Journal:  Int Urol Nephrol       Date:  2008-07-01       Impact factor: 2.370

3.  Clinical and epidemiological characteristics of young patients with Peyronie's disease: a retrospective study.

Authors:  Gianni Paulis; Giorgio Cavallini; Davide Barletta; Paolo Turchi; Antonio Vitarelli; Andrea Fabiani
Journal:  Res Rep Urol       Date:  2015-07-09

4.  Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study.

Authors:  Alessandro Zucchi; Elisabetta Costantini; Tommaso Cai; Giorgio Cavallini; Giovanni Liguori; Vincenzo Favilla; Gaetano De Grande; Giuseppe D'Achille; Mauro Silvani; Giorgio Franco; Alessandro Palmieri; Paolo Verze; Vincenzo Mirone
Journal:  Sex Med       Date:  2016-03-13       Impact factor: 2.491

5.  Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie's disease: a retrospective analysis of 309 cases.

Authors:  Gianni Paulis; Gennaro Romano; Andrea Paulis
Journal:  Res Rep Urol       Date:  2016-07-18

Review 6.  Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction.

Authors:  Jeffrey Campbell; Raidh Alzubaidi
Journal:  Transl Androl Urol       Date:  2017-02

Review 7.  The pathophysiology of Peyronie's disease.

Authors:  Ahmed I El-Sakka; Emre Salabas; Murat Dinçer; Ates Kadioglu
Journal:  Arab J Urol       Date:  2013-08-07

8.  Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study.

Authors:  Gianni Paulis; Davide Barletta; Paolo Turchi; Antonio Vitarelli; Giuseppe Dachille; Andrea Fabiani; Romano Gennaro
Journal:  Res Rep Urol       Date:  2015-12-31

9.  Clinical use of hyaluronic acid in andrology: A review.

Authors:  Alessandro Zucchi; Fabrizio Ildefonso Scroppo; Paolo Capogrosso; Andrea Salonia; Jacopo Duante; Vittorio Bini; Giovanni Liguori; Riccardo Bartoletti
Journal:  Andrology       Date:  2021-08-02       Impact factor: 4.456

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.